Amiloidózis: vizsgálatok itt: Svédország

In Svédország 15 Also abroad 184

15 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Where
Solna, Umeå
Életkor
18 év to 90 év
People
1200 worldwide
Run by
Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00
3. fázisCsak meghívásos
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Gothenburg, Solna, Umeå
Életkor
18 év and over
People
700 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT06679946
3. fázisTaking people
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Where
Huddinge, Umeå
Életkor
18 év and over
People
1280 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07207811
3. fázisTaking people
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Goteborg, Lund, Solna
Életkor
18 év to 85 év
People
1750 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00
3. fázisTaking people
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Where
Stockholm, Umea
Életkor
18 év to 85 év
People
125 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07223203 · EU 2025-522544-40-00
No phaseTaking people
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Where
Multiple Locations
Életkor
18 év and over
People
2000 worldwide
Run by
Bayer
See details and how to joinNCT07235462
No phaseTaking people
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Where
Södertälje, Umeå
People
52 121 worldwide
Run by
AstraZeneca
See details and how to joinNCT06355934
3. fázisNot yet taking people in Svédország
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
Where
Gothenburg, Lund, Skellefte, Stockholm
People
1180 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00
No phaseTaking people
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
Where
Gothenburg, Solna, Vasterbottens Lan
Életkor
18 év and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07690436
3. fázisNot yet taking people in Svédország
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Where
Umea
Életkor
18 év and over
People
250 worldwide
Run by
Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT07116473 · EU 2024-513676-18-00
3. fázisTaking people
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Where
Umea
Életkor
18 év to 75 év
People
587 worldwide
Run by
Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT06563895 · EU 2024-513547-82-00
2/3. fázisCsak meghívásos
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Where
Umea
Életkor
18 év and over
People
72 worldwide
Run by
Intellia Therapeutics
See details and how to joinNCT05697861 · EU 2023-507385-11-00
3. fázisCsak meghívásos
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Where
Gothenburg, Skellefteå
Életkor
18 év and over
People
1400 worldwide
Run by
Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493
No phaseNot yet taking people in Svédország
Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis
Where
Gothenburg, Linköping, Lund, Skellefteå, Stockholm, Umeå, Uppsala
Életkor
18 év and over
People
34 worldwide
Run by
Region Skane
See details and how to joinNCT07413081
No phaseCsak meghívásos
Sahlgrenska Cardiomyopathy Project
Where
Gothenburg
Életkor
18 év to 99 év
People
3000
Run by
Göteborg University
See details and how to joinNCT03527342